Health
Drug cuts COVID-19 deaths in hospitalized patients by two-thirds: study – Sports Grind Entertainment
An arthritis drug may cut deaths in hospitalized COVID-19 patients by about two thirds among those suffering from moderate or severe cases of the virus, according…
An arthritis drug may cut deaths in hospitalized COVID-19 patients by about two thirds among those suffering from moderate or severe cases of the virus, according to a new study.
Called baricitinib, and marketed under the brand name Olumiant, the medication has been touted by its British company as a possible game changer in the fight against COVID-19, the Daily Mail reported.
The rheumatoid arthritis drug, which has been available for only three years, was identified in February as a strong candidate…
-
Noosa News22 hours agoQueensland’s bid for net zero by 2050 unlikely under new energy plan: expert
-
General22 hours agoMaría Corina Machado awarded Nobel Peace Prize
-
General20 hours agoWestern Bulldogs extend Essendon’s losing streak with 57 point thrashing
-
Business10 hours agoThese 4 ASX mining stocks are rocketing as the rare earths boom intensifies